Synopsis of recent research by authors named "Sheri Trudeau"
- Sheri Trudeau's recent research primarily focuses on the treatment and management of chronic liver diseases, particularly primary biliary cholangitis (PBC) and hepatitis C virus (HCV) infections, emphasizing real-world treatment efficacy and patient care challenges.
- Trudeau's studies have identified gaps in the administration of standard treatments like ursodeoxycholic acid (UDCA) for PBC, noted the safety and efficacy of new treatments such as seladelpar, and highlighted the positive effects of antiviral therapy in reducing dementia risk among HCV patients.
- Additionally, her research evaluates the impacts of policy changes on organ transplantation outcomes and the effects of COVID-19 on liver disease hospitalizations, revealing significant trends and implications for healthcare strategies in managing these conditions.
